ANI Pharma (ANIP) Misses Q2 EPS by 16c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| ANI PHARMACEUTICALS (NASDAQ: ANIP) | Delayed: 72.69 -1.06 (1.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $73.75 | 52 Week High | $70.92 | |||
| Open | $73.30 | 52 Week Low | $26.80 | |||
| Day High | $73.42 | P/E | N/A | |||
| Day Low | $72.05 | EPS | $-0.96 | |||
| Volume | 73,790 | |||||
